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The subject of the study is the establishment of the role of bioenergetic 
(purinergic) in the pathogenesis of psoriasis disorders. For this purpose 
were examined 120 patients with psoriasis vulgaris  in progressive stage by 
ELISA (enzyme-linked immunosorbent assay) levels of cyclic nucleotide 
The imbalance of cAMP / cGMP levels were revealed may indicate not only 
functions violation of the second cellular mediators, but also signs of 
bioenergetics dysfunction with the development of changes neurotrophic 
functional  in psoriasis skin. 
Keywords: psoriasis, cyclic nucleotides, bioenergetics neurotrophic 
dysfunctions in the skin. 
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Доктор медицинских наук, доцент, Куц Л. В. Биоэнергетические 
аспекты псориаза / Медицинский институт Сумского 
государственного университета, Украина, Сумы 
Предмет исследования – установление роли биоэнергетических 
(пуринергических) нарушений в патогенезе псориаза. С этой целью 
клинически и при помощи иммуноферментного анализа уровней 
циклических нуклеотидов в крови обследовано 120 больных в 
прогрессирующей стадии вульгарного псориаза. Выявленный 
дисбаланс уровней цАМФ/цГМФ может свидетельствовать не 
только о нарушении функций вторых клеточных посредников, но и о 
признаках биоэнергетической дисфункции с развитием 
нейротрофических функциональных изменений в коже при псориазе. 
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_____________________________________________________________________ 
Introduction. Psoriasis is a common chronic disease, and this 
inflammatory dermatosis is registered approximately up to 5 million people 
of the world, and in total it is sick - about 200 million people on Earth [1, p. 
72-75; 2, p. 787-794; 3, p. 1198-1199; 4, p. 364-366]. A seronegative 
arthropathy is present up to 30% of all patients. But despite numerous 
studies of the etiology and pathogenesis of psoriasis, treatment of such 
patients doesn’t enough effective and complications from disease as 
arthropathy and erythroderma often occur often lead to disability of patients 
[5, p. 195-202]. 
One of the reasons for the existing problems of psoriasis may be 
insufficient consideration of the role of bioenergetic disorders of this 
disease. Essential in both the pathogenesis and clinical manifestations may 
be the fact of functional influences that usually stimulate the organs activity 
(tissues). This underlies the stereotyped form of neurogenic trophic 
disorders (neurodystrophy), one of the clinical manifestations of which in 
psoriasis are trophic skin lesions in the form of altered keratinization and 
epidermis regeneration[6].  
The aim of the study was to elucidate the significance of cyclic 
nucleotide content disorders in patients with psoriasis as a pathogenetic 
factor associated with dysfunction of bioenergetic metabolism in this 
dermatosis. 
Materials and methods. Generally observed of 120 patients during of 
progressive stage of psoriasis, of which 64 (53.3%) men, 56 (46.7%) 
women 18 to 40 years old, who subjected immunoassay analysis to find out 
in the blood cellular mediators - cyclic adenosine-5 "monophosphate 
(cAMP) and cyclic guanosine-5" monophosphate (cGMP).  The sets of test 
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systems "Cyclic AMP, 96" and "Cyclic GMP, 96" (pmol / ml), respectively 
were using.  
The control group consisted of 35 practically healthy people (20 men 
and 15 women 20 to 35 years old who did not have any acute inflammatory 
diseases and who did not take immunotropic and / or restorative drugs 
during the last 2 months. 
Statistical processing of the results was carried out on a personal 
computer using the licensed program "STATISTICA® for Windows 6.0".  
Results of the study and their discussion. Figure 1 shows the data 
that indicate a significant (p <0.05) decrease in the level of cAMP in patients 
with psoriasis (7.15 ± 0.82 pmol / ml) compared with the control group 
(10.64 ± 0, 62 pmol / ml).  
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Figure 1 – The blood content of cAMP (pmol / ml) in patients with 
psoriasis and those in the control group (significance of the difference 
* - p <0.05) 
According to the data shown in Fig. 2, in patients with psoriasis there is 
a significant (p <0.01) increase in blood cGMP (15.29 ± 1.56 pmol / ml), 
compared with the control group (6.76 ± 0.45 pmol / ml). 
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Figure 2 – Blood content of cGMP (pmol / ml) in patients with 
psoriasis and controls (reliability of differences ** - p <0.01) 
Thus, psoriasis patients have multidirectional changes secondary 
cellular mediators in the blood (in comparison with the control group), 
namely, a 1.4-fold decrease in cAMP and an average increase in cGMP by 
2.1 times. According to currently information, these disorders affect the 
mitotic cycle of keratinocytes and cause their uncontrolled division, since 
cAMP is an intracellular mitotic inhibitor (it level was significantly lowered), 
and cGMP on the contrary a proliferation stimulator (it level was significantly 
elevated) that leads to the development of structural (chemical) defects and 
as a consequence a functional character and manifests characteristic 
clinical changes known as «psoriatic skin». 
However the well-known fact about one of the key roles of cAMP / 
cGMP imbalance in the pathogenesis of psoriasis can have a new 
("bioenergetic") interpretation. Totally know that cAMP and cGMP are 
universal mediators of intracellular signaling and they participate in the 
transfer of adaptive-trophic influences of the neuroendocrine and immune 
system to the cells and tissues of the body psoriasis patients. According to 
currently biochemical studies, the human enzyme systems [7, p. 52] mainly 
synthesize nucleotide structures based on biomolecule precursors. In 
particular the sequential addition of carbon and nitrogen atoms to the 
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ribose-5-phosphate molecule provides the synthesis of de novo inosine-5 
"monophosphate (IMP) which is converted into adenosine-5" 
monophosphate (AMP) and guanosine-5 "monophosphate, and this way of 
synthesis requires considerable expenditure of metabolic energy. Receptors 
that perceive the signals of ATP and adenosine are classified as 
"purinergic". As a result of direct or mediated damage to receptors 
conducting neural pathways and neurons as well as their synaptic contacts 
(both pre- and postsynaptic formations) a kind of "functional denervation" 
and "isolation" is formed damaged tissue from nervous influences. Perhaps 
this explains the absence of pronounced nociceptive sensations in patients 
with psoriasis since such a "functional denervation" prevents the flow of 
intense signals into the focus of inflammation.  
Intercellular interactions of the neuro-trophic nature are carried out by 
the movement of the neuroplasma from the nucleus to the periphery of the 
neuron and in the opposite direction. The neuron and cells they contain as 
well as satellites (glia, Schwann cells, and connective tissue cells) form a 
certain regional trophic microsystem (the so-called "deterministic region") 
which functions as a single microsystem which is provided by intercellular 
interactions with the help of trophic factors - "trophogenes". Damage to this 
trophic contour or blockade of the axoplasmatic current that transports 
trophogens causes structural changes in both the skin and the 
corresponding neuron. Known trophogens refer to substances of protein 
(but possibly - and nucleic and other) nature and they have separated from 
the axon endings enter the synaptic cleft and from it move to the innervated 
cell. Regulators of this process include classical neurotransmitters which in 
turn change the level of the secondary intracellular mediator and such of 
them as cAMP and cGMP even through protein kinase mechanisms can 
affect the nuclear apparat and change the activity of genes that determine 
the formation of trophic factors. Known trophogens refer to substances of 
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protein (but possibly - and nucleic and other) nature, and they, having 
separated from the axon endings, enter the synaptic cleft, and from it move 
to the innervated cell. Regulators of this process include classical 
neurotransmitters, which Changes in nerve effects and neurotrophic 
function in turn affect microcirculation and formation of vascular exudative 
processes can increase the permeability of microvessel walls and damage 
endothelial cells. In one of the characteristic phenomena in psoriasis 
(Kebner) in extracellular space the concentration of adenine nucleotides the 
sources of which are not only damaged skin cells but also purinergic nerve 
endings or as a result of mechanical damage without disrupting the integrity 
of the skin (prolonged squeezing) also increases; such a source is platelets 
(as a result of mechanical damage with violation of the integrity of the skin - 
injections, injuries, etc.). However, with genetically determined cAMP 
deficiency in psoriasis patients, conditions are created to accumulate an 
excessive amount of its predecessors (including adenosine). Thus, the 
above-mentioned changes lead to disturbances in the provision of cells, first 
of all – postcapillary venules (a universal place for triggering the body's 
response in any form of inflammation) by high-energy compounds (ATP, 
ADP) and disrupt the energy exchange in the venous wall. 
Primary importance in the development of the inflammatory-reparative 
process is given to the endotheliocytes of postcapillary venules, and it is 
important to note that the main source of energy in them are the processes 
of aerobic glycolysis, and not oxidative phosphorylation. The content of ATP 
in these cells is several times higher than in cells of other types, and its 
value is extremely high, including because the ectonucleotidase system of 
the venous wall (ecto-ATP-ase, ecto-ADP-ase, ecto-AMP-ase) is an 
enzymatic cascade providing fast hydrolytic cleavage of extracellular 
adenine nucleotides (ATP, ADP, AMP) to adenosine. The same three 
enzymes regulate vascular tone (through the formation of adenosine - the 
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most active natural vasodilator), vascular platelet hemostasis (through 
changes in the concentration of ADP), purinergic neural effects on smooth 
myocytes. 
In smooth myocytes, which constitute the main population of cells and 
provide the majority of venous wall functions, bioenergetic processes also 
play a significant role, since there are several mechanisms of conjugation of 
excitation with the activity of myocytes. One such mechanism is associated 
with the development of the action potential and is characteristic of venous 
vessels that perform spontaneous contractile activity. The second 
mechanism is a prolonged depolarization of the membrane without 
development of the action potential which is typical for veins, which are not 
characterized by spontaneous electrical or contractile activity. Another 
"bioenergetic mechanism" that affects the functioning of the venous wall is 
to ensure its contraction without changing the membrane potential of 
smooth myocytes. 
Central to these energy disturbances is ATP since not only a number of 
such important processes as mechanical work biosynthesis and active 
transport of substances activation of substrates phosphorylation of 
enzymes and non-enzyme proteins are carried out due to accumulated 
energy in the wall of venous vessels but also - formation of cAMP. 
Violations of the processes of bioenergetic metabolism also concern the 
mechanisms of fine regulation of autonomic nervous centers, and this 
primarily concerns such processes as: a) regulation of glycolysis and tissue 
respiration (via ADP); b) regulation of glycogenolysis (via AMP, Ca++ ions 
and activation of adenylate cyclase); c) regulation through inhibition of 
phosphodiesterase (an enzyme catalyzing the conversion of cAMP to 5'-
AMP). 
Conclusions. The decrease in the level of cAMP in psoriasis patients 
the increase in cGMP may indicate not only the disturbances in the system 
Bioenergetics in medicine and biology № 1(1), 2017   ISSN 2523-6938 
 
of secondary intracellular intermediaries (cyclic nucleotides) but also the 
presence of bioenergetic (purinergic) imbalance which plays an important 
role in the development of clinical signs of this disease. 
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